In the ‘test–tube baby’ procedure:
1. | Fertilization is in-vitro but embryo development is in-vivo |
2. | Fertilization is in-vivo but embryo development is in-vitro |
3. | Both fertilization and embryo development are in-vitro |
4. | Both fertilization and embryo development are in-vivo |
The incidence of sexually transmitted infections is reported to be very high among persons in the age group of:
1. | 15 - 24 years | 2. | 25 - 34 years |
3. | 35 - 44 years | 4. | 45 - 54 years |
The introduction of sex education in schools in India should be encouraged. This is because:
I: | This will discourage children from believing in misconceptions about sex-related aspects |
II: | Sex education will help adolescents to lead a reproductively healthy life |
1. | Only I is correct |
2. | Only II is correct |
3. | Both I and II are correct |
4. | Both I and II are incorrect |
An ideal contraceptive should not:
1. Be user friendly
2. Be effective and reversible
3. Have the least side effects
4. Interfere with sexual drive
The ideal contraceptive for females who want to delay pregnancy and/or space children is:
1. Barrier contraceptive
2. Periodic abstinence
3. IUD
4. Hormonal pills
Which of the following is not a factor that has led to a population explosion in India?
1. | Decline in death rate |
2. | Decline in maternal mortality rate |
3. | Decline in Infant mortality rate |
4. | Decline in the number of people in reproducible age |
Which of the following STIs is not caused by a virus?
1. | Genital herpes | 2. | Genital warts |
3. | HIV | 4. | Syphilis |
Transfer of an ovum collected from a donor into the fallopian tube of another female is called as:
1. | ZIFT | 2. | GIFT |
3. | SUZI | 4. | ICSI |
The statutory marriageable age in India for males and females respectively are:
1. | 21, 18 | 2. | 18, 21 |
3. | 18, 18 | 4. | 21, 21 |
“Saheli” is a:
1. | NGO working for female child rights |
2. | Mid-wife working in villages to help with child immunization |
3. | A national helpline number for the prevention of crimes against wome |
4. | New oral contraceptive for females |